Pages that link to "Q41691216"

The following pages link to myc family DNA amplification in 107 tumors and tumor cell lines from patients with small cell lung cancer treated with different combination chemotherapy regimens (Q41691216):

Displaying 19 items.

• Origins, genetic landscape, and emerging therapies of small cell lung cancer (Q26798218) (← links)
• MicroRNA-218 is deleted and downregulated in lung squamous cell carcinoma (Q33691330) (← links)
• Progression-free survival: an important prognostic marker for long-term survival of small cell lung cancer (Q33728681) (← links)
• Chromosomal and genomic changes in lung cancer (Q33781119) (← links)
• Therapeutic priority of the PI3K/AKT/mTOR pathway in small cell lung cancers as revealed by a comprehensive genomic analysis (Q34134584) (← links)
• Targeting transcriptional addictions in small cell lung cancer with a covalent CDK7 inhibitor (Q34452854) (← links)
• Typical and atypical carcinoid tumors of the lung are characterized by 11q deletions as detected by comparative genomic hybridization (Q35753449) (← links)
• Knockdown of SUMO-activating enzyme subunit 2 (SAE2) suppresses cancer malignancy and enhances chemotherapy sensitivity in small cell lung cancer (Q35789345) (← links)
• Cross talk between the bombesin neuropeptide receptor and Sonic hedgehog pathways in small cell lung carcinoma. (Q35964491) (← links)
• Small-cell lung cancer is characterized by a high incidence of deletions on chromosomes 3p, 4q, 5q, 10q, 13q and 17p (Q36419914) (← links)
• Genetic changes in small cell lung carcinoma. (Q37138250) (← links)
• MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition. (Q39019412) (← links)
• Molecular biology of testicular germ cell tumors: current status (Q40922422) (← links)
• Resistance to chemotherapeutic antimetabolites: a function of salvage pathway involvement and cellular response to DNA damage (Q41398588) (← links)
• MYC amplification is associated with poor survival in small cell lung cancer: a chromogenic in situ hybridization study (Q44001809) (← links)
• Small-cell lung cancer: what we know, what we need to know and the path forward (Q47595394) (← links)
• Transcriptional deregulation underlying the pathogenesis of small cell lung cancer. (Q55011897) (← links)
• Recent progress in mapping the emerging landscape of the small-cell lung cancer genome (Q91890909) (← links)
• MYC-Driven Small-Cell Lung Cancer is Metabolically Distinct and Vulnerable to Arginine Depletion (Q92523787) (← links)